Yahoo
NSE - Delayed Quote INR

Torrent Pharmaceuticals Limited (TORNTPHARM.NS)

4,550.00 +25.60 (+0.57%)
At close: 3:28:08 PM GMT+5:30
Chart Range Bar
Loading chart for TORNTPHARM.NS
  • Previous Close 4,524.40
  • Open 4,561.10
  • Bid --
  • Ask --
  • Day's Range 4,466.80 - 4,626.60
  • 52 Week Range 3,532.60 - 5,250.00
  • Volume 658,312
  • Avg. Volume 379,918
  • Market Cap (intraday) 1.731T
  • Beta (5Y Monthly) 0.14
  • PE Ratio (TTM) 76.86
  • EPS (TTM) 59.20
  • Earnings Date Oct 23, 2026
  • Forward Dividend & Yield 38.00 (0.84%)
  • Ex-Dividend Date May 29, 2026
  • 1y Target Est 5,490.89

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

www.torrentpharma.com

18,258

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/26/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

TORNTPHARM.NS
19.23%
S&P BSE SENSEX (^BSESN)
13.63%

1-Year Return

TORNTPHARM.NS
28.17%
S&P BSE SENSEX (^BSESN)
12.59%

3-Year Return

TORNTPHARM.NS
147.85%
S&P BSE SENSEX (^BSESN)
16.56%

5-Year Return

TORNTPHARM.NS
228.16%
S&P BSE SENSEX (^BSESN)
19.98%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 49.79B
Earnings 5.34B
Profit Margin 10.73%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
10B
20B
30B
40B
10.0%
12.0%
14.0%
16.0%
18.0%

Analyst Insights

View More

Analyst Price Targets

4,545.00
5,490.89 Average
4,550.00 Current
6,194.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 10/23/2026
  • Market Cap

    1.72T

  • Enterprise Value

    1.85T

  • Trailing P/E

    72.27

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.21

  • Price/Book (mrq)

    20.52

  • Enterprise Value/Revenue

    11.95

  • Enterprise Value/EBITDA

    36.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.21%

  • Return on Assets (ttm)

    8.02%

  • Return on Equity (ttm)

    15.65%

  • Revenue (ttm)

    174B

  • Net Income Avi to Common (ttm)

    21.24B

  • Diluted EPS (ttm)

    59.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    29.86B

  • Total Debt/Equity (mrq)

    76.78%

  • Levered Free Cash Flow (ttm)

    35.97B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: